Study highlights AI limits in heart care

There are limits in applying AI to images of the heart, according to a new study from the Smidt Heart Institute at ...

New Post Hoc Analysis from the HELIOS-B Phase 3 Study Shows Vutrisiran Improved Measures of Heart Structure and Function in Patients with ATTR-CM

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced results from new post hoc analyses of the HELIOS-B Phase 3 study of AMVUTTRA® (vutrisiran), an RNAi ...

New gene discovery can help repair heart damage from heart attack or heart failure

Your heart will not just give you fear and uncertainty after a heart attack; it can leave scar tissue that stiffens your ...

Clinical Data Demonstrating Efficacy of Sotagliflozin in Preserved Ejection Fraction Heart Failure (HFpEF) without Diabetes Presented at American Heart Association (AHA) Annual ...

According to the American College of Cardiology, nearly 6.7 million Americans have heart failure, more than half with preserved ejection fraction. This condition often leads to frequent ...
Duke Pratt School of Engineering

Congenital Heart Disease Mutation Linked to Kidney Damage

Discovering the link between congenital heart disease and kidney problems could improve outcomes for patients with the ...
Healthline

Ventricles of the Brain: Their Function and Potential Disorders

Your brain ventricles are four fluid-filled chambers that produce cerebrospinal fluid. This fluid helps nourish your brain and protect it from injury. It would be easy to argue that your brain is the ...

Esperion Announces New Data from CLEAR Outcomes Highlighting Value of NEXLETOL® (bempedoic acid) in Oral and Poster Presentations at the AHA Scientific Sessions 2025

Analysis of Patients from CLEAR Outcomes Receiving No Other Background Lipid Lowering Therapies, Bempedoic Acid Alone Reduced MACE-4 by 14% ...